Search

everythinglearnresearchcommunity

for

Search:↓

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Some vegetables from Northern Thailand show promise for health benefits, including hair loss treatment and antioxidant properties.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

PCOS is common in women, often treated with lifestyle changes and oral contraceptives.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Both HPSAM and PLS methods accurately measure minoxidil and tretinoin concentrations.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

New method effectively detects illegal hormones in anti-aging foods.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.